Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation

Summary Pericardial effusion (PE) is a rare but potentially life‐threatening complication for allogeneic haematopoietic stem cell transplantation (HSCT) recipients. The risk factors, aetiology, incidence and therapy are largely unclear. To investigate this issue, we reviewed 391 adult patients under...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2015-06, Vol.169 (5), p.737-745
Hauptverfasser: Liu, Yao‐Chung, Chien, Sheng‐Hsuan, Fan, Nai‐Wen, Hu, Ming‐Hung, Gau, Jyh‐Pyng, Liu, Chia‐Jen, Yu, Yuan‐Bin, Liu, Chun‐Yu, Hsiao, Liang‐Tsai, Liu, Jin‐Hwang, Chiou, Tzeon‐Jye, Tzeng, Cheng‐Hwai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 745
container_issue 5
container_start_page 737
container_title British journal of haematology
container_volume 169
creator Liu, Yao‐Chung
Chien, Sheng‐Hsuan
Fan, Nai‐Wen
Hu, Ming‐Hung
Gau, Jyh‐Pyng
Liu, Chia‐Jen
Yu, Yuan‐Bin
Liu, Chun‐Yu
Hsiao, Liang‐Tsai
Liu, Jin‐Hwang
Chiou, Tzeon‐Jye
Tzeng, Cheng‐Hwai
description Summary Pericardial effusion (PE) is a rare but potentially life‐threatening complication for allogeneic haematopoietic stem cell transplantation (HSCT) recipients. The risk factors, aetiology, incidence and therapy are largely unclear. To investigate this issue, we reviewed 391 adult patients undergoing allogeneic HSCT between January 2003 and December 2013. Twelve out of 391 patients (3·1%) developed PE of moderate to large amounts, including 9 out of 12 patients (75%) identified as late‐onset PE. Two out of the nine patients with late‐onset PE experienced recurrent effusion. The median age at HSCT was 44·5 years (range: 22–63 years) among the 12 patients with PE and 47 years in the late‐onset patients. Multivariate analysis revealed that multiple transplant procedures was a significant risk factor for PE (P = 0·036) and a trend as risk factor in patients aged>50 years (P = 0·066). For late‐onset PE, pre‐transplant age>50 years (P = 0·032) and extensive chronic graft‐versus‐host disease (cGVHD) (P = 0·006) remained statistically significant on multivariate analysis. Currently, there are no published data exploring the risk factors for post‐transplant PE in adult patients of allogeneic HSCT. Our study determined the risk factors and incidence for the post‐transplant PE, especially in the late‐onset group.
doi_str_mv 10.1111/bjh.13357
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1681260856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1681260856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3917-4bb4844089c41d6310fc54b23b55e0c625cc851f30489fe958b41ee1944eec263</originalsourceid><addsrcrecordid>eNp1kMFO3DAQhi0Egi3toS9Q-UgPAU9sZ51ju6JdEBISgnPkeMeLqWOntkPF25Pt0t6Yy2ikb37NfIR8BnYOc130T4_nwLlcHpAF8EZWNQg4JAvG2LICJtQJ-ZDzE2PAmYRjclJLBUoJtiDTncu_qNWmxJSpjYmOmJzRaeO0p2jtlF0M1AWqN5MvdNTFYSiZJjTonl3YUu193GJAZ-ijxkGXOEaHZR5zwYEa9J6WpEMevQ5l3o_hIzmy2mf89NZPycOPy_vVurq5_Xm1-nZTGd7CshJ9L5QQTLVGwKbhwKyRoq95LyUy09TSGCXB8vnF1mIrVS8AEVohEE3d8FNyts8dU_w9YS7d4PLuIB0wTrmDRkHdMCV36Nc9alLMOaHtxuQGnV46YN3Ocjdb7v5antkvb7FTP-DmP_lP6wxc7IE_zuPL-0nd9-v1PvIVQOCIPA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681260856</pqid></control><display><type>article</type><title>Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><creator>Liu, Yao‐Chung ; Chien, Sheng‐Hsuan ; Fan, Nai‐Wen ; Hu, Ming‐Hung ; Gau, Jyh‐Pyng ; Liu, Chia‐Jen ; Yu, Yuan‐Bin ; Liu, Chun‐Yu ; Hsiao, Liang‐Tsai ; Liu, Jin‐Hwang ; Chiou, Tzeon‐Jye ; Tzeng, Cheng‐Hwai</creator><creatorcontrib>Liu, Yao‐Chung ; Chien, Sheng‐Hsuan ; Fan, Nai‐Wen ; Hu, Ming‐Hung ; Gau, Jyh‐Pyng ; Liu, Chia‐Jen ; Yu, Yuan‐Bin ; Liu, Chun‐Yu ; Hsiao, Liang‐Tsai ; Liu, Jin‐Hwang ; Chiou, Tzeon‐Jye ; Tzeng, Cheng‐Hwai</creatorcontrib><description>Summary Pericardial effusion (PE) is a rare but potentially life‐threatening complication for allogeneic haematopoietic stem cell transplantation (HSCT) recipients. The risk factors, aetiology, incidence and therapy are largely unclear. To investigate this issue, we reviewed 391 adult patients undergoing allogeneic HSCT between January 2003 and December 2013. Twelve out of 391 patients (3·1%) developed PE of moderate to large amounts, including 9 out of 12 patients (75%) identified as late‐onset PE. Two out of the nine patients with late‐onset PE experienced recurrent effusion. The median age at HSCT was 44·5 years (range: 22–63 years) among the 12 patients with PE and 47 years in the late‐onset patients. Multivariate analysis revealed that multiple transplant procedures was a significant risk factor for PE (P = 0·036) and a trend as risk factor in patients aged&gt;50 years (P = 0·066). For late‐onset PE, pre‐transplant age&gt;50 years (P = 0·032) and extensive chronic graft‐versus‐host disease (cGVHD) (P = 0·006) remained statistically significant on multivariate analysis. Currently, there are no published data exploring the risk factors for post‐transplant PE in adult patients of allogeneic HSCT. Our study determined the risk factors and incidence for the post‐transplant PE, especially in the late‐onset group.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.13357</identifier><identifier>PMID: 25818840</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; Aged ; cardiac tamponade ; Female ; Graft vs Host Disease - etiology ; Graft vs Host Disease - prevention &amp; control ; graft‐versus‐host disease ; Hematopoietic Stem Cell Transplantation - adverse effects ; Humans ; Incidence ; Male ; Middle Aged ; Patient Outcome Assessment ; pericardial effusion ; Pericardial Effusion - epidemiology ; Pericardial Effusion - etiology ; Pericardial Effusion - mortality ; Retrospective Studies ; Risk Factors ; stem cell transplantation ; Transplantation Conditioning - adverse effects ; Transplantation, Homologous ; Young Adult</subject><ispartof>British journal of haematology, 2015-06, Vol.169 (5), p.737-745</ispartof><rights>2015 John Wiley &amp; Sons Ltd</rights><rights>2015 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3917-4bb4844089c41d6310fc54b23b55e0c625cc851f30489fe958b41ee1944eec263</citedby><cites>FETCH-LOGICAL-c3917-4bb4844089c41d6310fc54b23b55e0c625cc851f30489fe958b41ee1944eec263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.13357$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.13357$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25818840$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yao‐Chung</creatorcontrib><creatorcontrib>Chien, Sheng‐Hsuan</creatorcontrib><creatorcontrib>Fan, Nai‐Wen</creatorcontrib><creatorcontrib>Hu, Ming‐Hung</creatorcontrib><creatorcontrib>Gau, Jyh‐Pyng</creatorcontrib><creatorcontrib>Liu, Chia‐Jen</creatorcontrib><creatorcontrib>Yu, Yuan‐Bin</creatorcontrib><creatorcontrib>Liu, Chun‐Yu</creatorcontrib><creatorcontrib>Hsiao, Liang‐Tsai</creatorcontrib><creatorcontrib>Liu, Jin‐Hwang</creatorcontrib><creatorcontrib>Chiou, Tzeon‐Jye</creatorcontrib><creatorcontrib>Tzeng, Cheng‐Hwai</creatorcontrib><title>Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary Pericardial effusion (PE) is a rare but potentially life‐threatening complication for allogeneic haematopoietic stem cell transplantation (HSCT) recipients. The risk factors, aetiology, incidence and therapy are largely unclear. To investigate this issue, we reviewed 391 adult patients undergoing allogeneic HSCT between January 2003 and December 2013. Twelve out of 391 patients (3·1%) developed PE of moderate to large amounts, including 9 out of 12 patients (75%) identified as late‐onset PE. Two out of the nine patients with late‐onset PE experienced recurrent effusion. The median age at HSCT was 44·5 years (range: 22–63 years) among the 12 patients with PE and 47 years in the late‐onset patients. Multivariate analysis revealed that multiple transplant procedures was a significant risk factor for PE (P = 0·036) and a trend as risk factor in patients aged&gt;50 years (P = 0·066). For late‐onset PE, pre‐transplant age&gt;50 years (P = 0·032) and extensive chronic graft‐versus‐host disease (cGVHD) (P = 0·006) remained statistically significant on multivariate analysis. Currently, there are no published data exploring the risk factors for post‐transplant PE in adult patients of allogeneic HSCT. Our study determined the risk factors and incidence for the post‐transplant PE, especially in the late‐onset group.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>cardiac tamponade</subject><subject>Female</subject><subject>Graft vs Host Disease - etiology</subject><subject>Graft vs Host Disease - prevention &amp; control</subject><subject>graft‐versus‐host disease</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Outcome Assessment</subject><subject>pericardial effusion</subject><subject>Pericardial Effusion - epidemiology</subject><subject>Pericardial Effusion - etiology</subject><subject>Pericardial Effusion - mortality</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>stem cell transplantation</subject><subject>Transplantation Conditioning - adverse effects</subject><subject>Transplantation, Homologous</subject><subject>Young Adult</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFO3DAQhi0Egi3toS9Q-UgPAU9sZ51ju6JdEBISgnPkeMeLqWOntkPF25Pt0t6Yy2ikb37NfIR8BnYOc130T4_nwLlcHpAF8EZWNQg4JAvG2LICJtQJ-ZDzE2PAmYRjclJLBUoJtiDTncu_qNWmxJSpjYmOmJzRaeO0p2jtlF0M1AWqN5MvdNTFYSiZJjTonl3YUu193GJAZ-ijxkGXOEaHZR5zwYEa9J6WpEMevQ5l3o_hIzmy2mf89NZPycOPy_vVurq5_Xm1-nZTGd7CshJ9L5QQTLVGwKbhwKyRoq95LyUy09TSGCXB8vnF1mIrVS8AEVohEE3d8FNyts8dU_w9YS7d4PLuIB0wTrmDRkHdMCV36Nc9alLMOaHtxuQGnV46YN3Ocjdb7v5antkvb7FTP-DmP_lP6wxc7IE_zuPL-0nd9-v1PvIVQOCIPA</recordid><startdate>201506</startdate><enddate>201506</enddate><creator>Liu, Yao‐Chung</creator><creator>Chien, Sheng‐Hsuan</creator><creator>Fan, Nai‐Wen</creator><creator>Hu, Ming‐Hung</creator><creator>Gau, Jyh‐Pyng</creator><creator>Liu, Chia‐Jen</creator><creator>Yu, Yuan‐Bin</creator><creator>Liu, Chun‐Yu</creator><creator>Hsiao, Liang‐Tsai</creator><creator>Liu, Jin‐Hwang</creator><creator>Chiou, Tzeon‐Jye</creator><creator>Tzeng, Cheng‐Hwai</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201506</creationdate><title>Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation</title><author>Liu, Yao‐Chung ; Chien, Sheng‐Hsuan ; Fan, Nai‐Wen ; Hu, Ming‐Hung ; Gau, Jyh‐Pyng ; Liu, Chia‐Jen ; Yu, Yuan‐Bin ; Liu, Chun‐Yu ; Hsiao, Liang‐Tsai ; Liu, Jin‐Hwang ; Chiou, Tzeon‐Jye ; Tzeng, Cheng‐Hwai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3917-4bb4844089c41d6310fc54b23b55e0c625cc851f30489fe958b41ee1944eec263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>cardiac tamponade</topic><topic>Female</topic><topic>Graft vs Host Disease - etiology</topic><topic>Graft vs Host Disease - prevention &amp; control</topic><topic>graft‐versus‐host disease</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Outcome Assessment</topic><topic>pericardial effusion</topic><topic>Pericardial Effusion - epidemiology</topic><topic>Pericardial Effusion - etiology</topic><topic>Pericardial Effusion - mortality</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>stem cell transplantation</topic><topic>Transplantation Conditioning - adverse effects</topic><topic>Transplantation, Homologous</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yao‐Chung</creatorcontrib><creatorcontrib>Chien, Sheng‐Hsuan</creatorcontrib><creatorcontrib>Fan, Nai‐Wen</creatorcontrib><creatorcontrib>Hu, Ming‐Hung</creatorcontrib><creatorcontrib>Gau, Jyh‐Pyng</creatorcontrib><creatorcontrib>Liu, Chia‐Jen</creatorcontrib><creatorcontrib>Yu, Yuan‐Bin</creatorcontrib><creatorcontrib>Liu, Chun‐Yu</creatorcontrib><creatorcontrib>Hsiao, Liang‐Tsai</creatorcontrib><creatorcontrib>Liu, Jin‐Hwang</creatorcontrib><creatorcontrib>Chiou, Tzeon‐Jye</creatorcontrib><creatorcontrib>Tzeng, Cheng‐Hwai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yao‐Chung</au><au>Chien, Sheng‐Hsuan</au><au>Fan, Nai‐Wen</au><au>Hu, Ming‐Hung</au><au>Gau, Jyh‐Pyng</au><au>Liu, Chia‐Jen</au><au>Yu, Yuan‐Bin</au><au>Liu, Chun‐Yu</au><au>Hsiao, Liang‐Tsai</au><au>Liu, Jin‐Hwang</au><au>Chiou, Tzeon‐Jye</au><au>Tzeng, Cheng‐Hwai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2015-06</date><risdate>2015</risdate><volume>169</volume><issue>5</issue><spage>737</spage><epage>745</epage><pages>737-745</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary Pericardial effusion (PE) is a rare but potentially life‐threatening complication for allogeneic haematopoietic stem cell transplantation (HSCT) recipients. The risk factors, aetiology, incidence and therapy are largely unclear. To investigate this issue, we reviewed 391 adult patients undergoing allogeneic HSCT between January 2003 and December 2013. Twelve out of 391 patients (3·1%) developed PE of moderate to large amounts, including 9 out of 12 patients (75%) identified as late‐onset PE. Two out of the nine patients with late‐onset PE experienced recurrent effusion. The median age at HSCT was 44·5 years (range: 22–63 years) among the 12 patients with PE and 47 years in the late‐onset patients. Multivariate analysis revealed that multiple transplant procedures was a significant risk factor for PE (P = 0·036) and a trend as risk factor in patients aged&gt;50 years (P = 0·066). For late‐onset PE, pre‐transplant age&gt;50 years (P = 0·032) and extensive chronic graft‐versus‐host disease (cGVHD) (P = 0·006) remained statistically significant on multivariate analysis. Currently, there are no published data exploring the risk factors for post‐transplant PE in adult patients of allogeneic HSCT. Our study determined the risk factors and incidence for the post‐transplant PE, especially in the late‐onset group.</abstract><cop>England</cop><pmid>25818840</pmid><doi>10.1111/bjh.13357</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2015-06, Vol.169 (5), p.737-745
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_1681260856
source MEDLINE; Access via Wiley Online Library; Wiley Online Library (Open Access Collection)
subjects Adolescent
Adult
Aged
cardiac tamponade
Female
Graft vs Host Disease - etiology
Graft vs Host Disease - prevention & control
graft‐versus‐host disease
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Incidence
Male
Middle Aged
Patient Outcome Assessment
pericardial effusion
Pericardial Effusion - epidemiology
Pericardial Effusion - etiology
Pericardial Effusion - mortality
Retrospective Studies
Risk Factors
stem cell transplantation
Transplantation Conditioning - adverse effects
Transplantation, Homologous
Young Adult
title Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20pericardial%20effusion%20in%20adult%20patients%20receiving%20allogeneic%20haematopoietic%20stem%20cell%20transplantation&rft.jtitle=British%20journal%20of%20haematology&rft.au=Liu,%20Yao%E2%80%90Chung&rft.date=2015-06&rft.volume=169&rft.issue=5&rft.spage=737&rft.epage=745&rft.pages=737-745&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.13357&rft_dat=%3Cproquest_cross%3E1681260856%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1681260856&rft_id=info:pmid/25818840&rfr_iscdi=true